TNF and type 2 diabetes mellitus: In addition to its tissue direct effects on IR, TNF regulates pro-inflammatory markers, such as IL-6 and lipocalin-2 (LCN2) that are implicated in the pathogenesis of hepatic steatosis and T2D onset and progression [14–16].